- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
-
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
-
March 10, 2023Robins Kaplan Announces $28 Million Settlement in Case Against For-Profit College’s Directors & Officers
-
March 29-30, 2023ACI Managed Care Disputes and Litigation
-
April 3, 2023Conference of Tribal Lending Commissioners
-
April 11-13, 2023Mass Torts Made Perfect Seminar
-
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
-
February 22, 2023A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
-
February 7, 2023When Monkey Business Slips Into Trademark Infringement
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Robins Kaplan LLP Named a Recommended Firm for Hatch-Waxman by LMG Life Sciences
December 1, 2016
Robins Kaplan LLP is pleased to announce that LMG Life Sciences has recommended the firm as a top Hatch-Waxman patent litigation firm for generic pharmaceutical companies. LMG Life Sciences also named two members of Robins Kaplan’s Hatch-Waxman Litigation practice group “Life Science Stars.” Recipients include:
The recognition is a reflection of the firm’s successful representation of generic pharmaceutical companies, as well as the sophisticated legal and scientific understanding of the attorneys who practice in the field. Recipients were chosen based on nearly 1,000 interviews and surveys, including firm-wide surveys, interviews with individual attorneys and clients, and a review of public information.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.